MANKIND vs RELIANCE
Head-to-head DCF comparison · Mankind Pharma Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
MANKIND
Mankind Pharma Limited
Pharma
₹2,105
OvervaluedRELIANCE
Reliance Industries
Oil & Gas
₹1,353
Fairly Valued| Metric | MANKIND | RELIANCE |
|---|---|---|
| Verdict | Overvalued | Fairly Valued |
| YieldIQ Score | 40/100 | 48/100 |
| Fair Value | ₹1,299 | ₹1,266 |
| Current Price | ₹2,105 | ₹1,353 |
| Margin of Safety | -38.3% | -6.4% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 5/9 | 6/9 |
| ROE | 13.7% | 6.9% |
| Debt / Equity | — | — |
| EV / EBITDA | 26.5× | 14.3× |
| Market Cap | ₹0.87 Lakh Cr | ₹18.31 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.